Muscle-targeted gene therapy in glycogen storage disease type II with adeno-associated virus serotypes 7, 8, and 9

被引:0
|
作者
Sun, Baodong [1 ]
Hauschka, Stephen [2 ]
Bird, Andrew [1 ]
Auten, Richard [3 ]
Koeberl, Divight [1 ]
机构
[1] Duke Univ, Med Ctr, Dept Pediat, Div Med Genet, Durham, NC 27706 USA
[2] Univ Washington, Dept Biochem, Seattle, WA 98195 USA
[3] Duke Univ, Med Ctr, Dept Pediat, Div Neonatol, Durham, NC 27706 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
95
引用
收藏
页码:S38 / S39
页数:2
相关论文
共 50 条
  • [41] Adeno-associated virus 9 gene therapy for juvenile neuronal ceroid lipofuscinosis
    Kielian, Tammy
    Bosch, Megan E.
    Aldrich, Amy
    Fallet, Rachel
    Foust, Kevin D.
    MOLECULAR GENETICS AND METABOLISM, 2016, 117 (02) : S67 - S67
  • [42] Adeno-associated Virus 9 Vector in the Gene Therapy of Occlusive Vascular Diseases
    Agrawal, Devendra Kumar
    Pankajakshan, Divya
    Del Core, Michael
    Pipinos, Iraklis
    Hatzoudis, George
    FASEB JOURNAL, 2010, 24
  • [43] ADENO-ASSOCIATED VIRUS 9 VECTOR IN THE GENE THERAPY OF OCCLUSIVE VASCULAR DISEASES
    Agrawal, D.
    Pankajakshan, D.
    Del Core, M.
    Pipinos, I.
    Hatzoudis, G.
    ATHEROSCLEROSIS SUPPLEMENTS, 2010, 11 (02) : 17 - 17
  • [44] Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges
    Zhao, Liyuan
    Yang, Zixuan
    Zheng, Minhui
    Shi, Lei
    Gu, Mengyun
    Liu, Gang
    Miao, Feng
    Chang, Yan
    Huang, Fanghua
    Tang, Naping
    GENES & DISEASES, 2024, 11 (01) : 283 - 293
  • [45] Hepatorenal Correction in Murine Glycogen Storage Disease Type I With a Double-stranded Adeno-associated Virus Vector
    Luo, Xiaoyan
    Hall, Gentzon
    Li, Songtao
    Bird, Andrew
    Lavin, Peter J.
    Winn, Michelle P.
    Kemper, Alex R.
    Brown, Talmage T.
    Koeberl, Dwight D.
    MOLECULAR THERAPY, 2011, 19 (11) : 1961 - 1970
  • [46] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia (vol 13, pg 1281, 2006)
    Koeberl, D. D.
    Sun, B. D.
    Damodaran, T. V.
    Brown, T.
    Millington, D. S.
    Benjamin, D. K., Jr.
    Bird, A.
    Schneider, A.
    Hillman, S.
    Jackson, M.
    Beaty, R. M.
    Chen, Y. T.
    GENE THERAPY, 2007, 14 (03) : 281 - 281
  • [47] Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia (vol 13, pg 1281, 2006)
    Koeberl, D. D.
    Sun, B. D.
    Damodaran, T. V.
    Brown, T.
    Millington, D. S.
    Benjamin, D. K., Jr.
    Bird, A.
    Schneider, A.
    Hillman, S.
    Jackson, M.
    Beaty, R. M.
    Chen, Y. T.
    GENE THERAPY, 2006, 13 (19) : 1430 - 1430
  • [48] ADENO-ASSOCIATED VIRUS (AAV) TYPE-8 MEDIATED SYSTEMIC NEONATAL GENE THERAPY FOR HYPOPHOSPHATASIA
    Matsumoto, Tae
    Yamamoto, Seiko
    Miyake, Koichi
    Miyake, Noriko
    Orimo, Hideo
    Shimada, Takashi
    JOURNAL OF GENE MEDICINE, 2010, 12 (12): : 1064 - 1064
  • [49] Adeno associated vector-based gene therapy strategy for type 3 glycogen storage disease
    Vidal, P.
    Ronzitti, G.
    Collaud, F.
    Sola, M. Simon
    Collela, P.
    Puzzo, F.
    Verdera, H. Costa
    Charles, S.
    Vignaud, A.
    Van Wittenberghe, L.
    Gjata, B.
    Gjorgjieva, M.
    Laforet, P.
    Rajas, F.
    Malfatti, E.
    Comi, G.
    Mingozzi, F.
    NEUROMUSCULAR DISORDERS, 2017, 27 : S246 - S246
  • [50] Proximal Tubule-Targeted Adeno-Associated Virus (AAV) Gene Therapy for Cystinuria
    Peek, Jennifer L.
    Rosales, Alan
    Qi, Julie
    Menshikh, Anna
    Welch, Richard C.
    Bock, Fabian
    Woodard, Lauren Elizabeth
    Asokan, Aravind
    Wilson, Matthew H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):